jueves, 19 de septiembre de 2013

Study finds medical panellists have links to pharmaceutical industry / RAY MOYNIHAN


A study of the people who make up the expert US disease panels, which make changes to the definitions and diagnostic factors of common conditions, has found that 75 per cent of them have links to major medical and pharmaceutical companies.  
The panel members make recommendations on conditions like hypertension, cholesterol, Alzheimer's disease and rheumatoid arthritis. These recommendations can lead to more preventative medication being prescribed.

Ver (y escuchar)
Publicar un comentario en la entrada